HIGHLIGHTS
- who: Elena Ioana Braicu from the Department of Obstetrics and Gynecology, Stanford University, California, USA have published the Article: HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients, in the Journal: (JOURNAL)
- what: The aim of this prospective study was to evaluate the diagnostic value of adding HE4, CA125 and ROMA to transvaginal ultrasound (TVUS) for detecting ovarian cancer in patients presenting with a pelvic mass. All patients provided written informed consent for the use of their blood samples for research purposes. The authors report the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.